Myocardial phosphoproteomics and single cardiomyocyte force measurements endorse DYRK1A as a candidate therapeutic target for incomplete myocardial reverse remodelling after aortic valve replacement

Ex vivo modelling of cardiac injury identifies ferroptosis as a therapeutic entry route for translational medicine

Cardiomyocyte-specific beta3-adrenergic receptor expression reduces infarct size inhibiting apoptosis and promoting mitochondrial biogenesis in mice

Fast but not furious: neonatal cardiac fibroblasts as promoters of regeneration after myocardial infarction

Extracellular matrix protein 1 as a novel mediator of inflammation-to-fibrosis progression after myocardial infarction